Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Brain morphological abnormalities in genetic generalized epilepsies: The starting point?

Coan AC.

Epilepsia. 2019 Jul;60(7):1279-1280. doi: 10.1111/epi.16101. Epub 2019 Jun 24. No abstract available.

PMID:
31233212
2.

Multimodal Analysis of SCN1A Missense Variants Improves Interpretation of Clinically Relevant Variants in Dravet Syndrome.

Gonsales MC, Montenegro MA, Preto P, Guerreiro MM, Coan AC, Quast MP, Carvalho BS, Lopes-Cendes I.

Front Neurol. 2019 Mar 28;10:289. doi: 10.3389/fneur.2019.00289. eCollection 2019.

3.

Neuropsychological and neuroimaging evidences of cerebral dysfunction in stroke-free patients with atrial fibrillation: A review.

Silva DS, Coan AC, Avelar WM.

J Neurol Sci. 2019 Apr 15;399:172-181. doi: 10.1016/j.jns.2019.02.027. Epub 2019 Feb 18. Review.

PMID:
30825695
4.

Corrigendum: Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis.

Pamplona FA, da Silva LR, Coan AC.

Front Neurol. 2019 Jan 10;9:1050. doi: 10.3389/fneur.2018.01050. eCollection 2018.

5.

Epilepsy for primary health care: a cost-effective Latin American E-learning initiative.

Carrizosa J, Braga P, Albuquerque M, Bogacz A, Burneo J, Coan AC, Contreras G, Guilhoto L, Izquierdo Á, Ladino L, Lin K, Manreza ML, Morales L, Ríos L, Solarte R, Valente K, Venegas V, Uscátegui-Daccarett A, Yacubian EM.

Epileptic Disord. 2018 Oct 1;20(5):386-395. doi: 10.1684/epd.2018.0997.

6.

Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis.

Pamplona FA, da Silva LR, Coan AC.

Front Neurol. 2018 Sep 12;9:759. doi: 10.3389/fneur.2018.00759. eCollection 2018. Erratum in: Front Neurol. 2019 Jan 10;9:1050.

7.

Differences in Cortical Structure and Functional MRI Connectivity in High Functioning Autism.

Pereira AM, Campos BM, Coan AC, Pegoraro LF, de Rezende TJR, Obeso I, Dalgalarrondo P, da Costa JC, Dreher JC, Cendes F.

Front Neurol. 2018 Jul 10;9:539. doi: 10.3389/fneur.2018.00539. eCollection 2018.

8.

Higher IQ in juvenile myoclonic epilepsy: Dodging cognitive obstacles and "masking" impairments.

Rzezak P, Moschetta SP, Mendonça M, Paiva MLMN, Coan AC, Guerreiro C, Valente KDR.

Epilepsy Behav. 2018 Sep;86:124-130. doi: 10.1016/j.yebeh.2018.05.029. Epub 2018 Jul 14.

PMID:
30017836
9.

Effects of cervical manipulation on pain, grip force control, and upper extremity muscle activity: a randomized controlled trial.

Bracht MA, Coan ACB, Yahya A, Dos Santos MJ.

J Man Manip Ther. 2018 May;26(2):78-88. doi: 10.1080/10669817.2017.1393177. Epub 2017 Oct 31.

10.

Default Mode Network Disruption in Stroke-Free Patients with Atrial Fibrillation.

Silva DS, Avelar WM, de Campos BM, Lino APBL, Balthazar MLF, Figueiredo MJO, Cendes F, Coan AC.

Cerebrovasc Dis. 2018;45(1-2):78-84. doi: 10.1159/000486689. Epub 2018 Mar 2.

PMID:
29502113
11.

Dysregulation of NEUROG2 plays a key role in focal cortical dysplasia.

Avansini SH, Torres FR, Vieira AS, Dogini DB, Rogerio F, Coan AC, Morita ME, Guerreiro MM, Yasuda CL, Secolin R, Carvalho BS, Borges MG, Almeida VS, Araújo PAOR, Queiroz L, Cendes F, Lopes-Cendes I.

Ann Neurol. 2018 Mar;83(3):623-635. doi: 10.1002/ana.25187. Epub 2018 Mar 10.

12.

Is inpatient ictal video-electroencephalographic monitoring mandatory in mesial temporal lobe epilepsy with unilateral hippocampal sclerosis? A prospective study.

Alvim MKM, Morita ME, Yasuda CL, Damasceno BP, Lopes TM, Coan AC, Ghizoni E, Tedeschi H, Cendes F.

Epilepsia. 2018 Feb;59(2):410-419. doi: 10.1111/epi.13977. Epub 2017 Dec 13.

13.

Sleep onset uncovers thalamic abnormalities in patients with idiopathic generalised epilepsy.

Bagshaw AP, Hale JR, Campos BM, Rollings DT, Wilson RS, Alvim MKM, Coan AC, Cendes F.

Neuroimage Clin. 2017 Jul 12;16:52-57. doi: 10.1016/j.nicl.2017.07.008. eCollection 2017.

14.

Electroencephalography Patterns and Prognosis in Acute Ischemic Stroke.

Lima FO, Ricardo JAG, Coan AC, Soriano DC, Avelar WM, Min LL.

Cerebrovasc Dis. 2017;44(3-4):128-134. doi: 10.1159/000477674. Epub 2017 Jun 13.

PMID:
28605741
15.

Concurrent mood and anxiety disorders are associated with pharmacoresistant seizures in patients with MTLE.

Nogueira MH, Yasuda CL, Coan AC, Kanner AM, Cendes F.

Epilepsia. 2017 Jul;58(7):1268-1276. doi: 10.1111/epi.13781. Epub 2017 May 26.

16.

MicroRNA hsa-miR-134 is a circulating biomarker for mesial temporal lobe epilepsy.

Avansini SH, de Sousa Lima BP, Secolin R, Santos ML, Coan AC, Vieira AS, Torres FR, Carvalho BS, Alvim MK, Morita ME, Yasuda CL, Pimentel-Silva LR, Dogini DB, Rogerio F, Cendes F, Lopes-Cendes I.

PLoS One. 2017 Apr 6;12(4):e0173060. doi: 10.1371/journal.pone.0173060. eCollection 2017.

17.

Abnormality in hippocampal signal intensity predicts atrophy in patients with systemic lupus erythematosus.

Lapa AT, Pedro T, Francischinelli J, Coan AC, Costallat LT, Cendes F, Appenzeller S.

Lupus. 2017 May;26(6):633-639. doi: 10.1177/0961203316673151. Epub 2016 Nov 23.

PMID:
27879427
18.

Translation and validation into Brazilian Portuguese of the Spastic Paraplegia Rating Scale (SPRS).

Servelhere KR, Faber I, Coan AC, França M Junior.

Arq Neuropsiquiatr. 2016 Jun;74(6):489-94. doi: 10.1590/0004-282X20160047.

19.

In response: Brain atrophy in seizure-free temporal lobe epilepsy: Implications for predicting pharmacoresistance.

Alvim MK, Coan AC, Yasuda CL, Morita ME, Cendes F.

Epilepsia. 2016 May;57(5):856-7. doi: 10.1111/epi.13379. No abstract available.

20.

Large-scale brain networks are distinctly affected in right and left mesial temporal lobe epilepsy.

de Campos BM, Coan AC, Lin Yasuda C, Casseb RF, Cendes F.

Hum Brain Mapp. 2016 Sep;37(9):3137-52. doi: 10.1002/hbm.23231. Epub 2016 May 2.

21.

Progression of gray matter atrophy in seizure-free patients with temporal lobe epilepsy.

Alvim MK, Coan AC, Campos BM, Yasuda CL, Oliveira MC, Morita ME, Cendes F.

Epilepsia. 2016 Apr;57(4):621-9. doi: 10.1111/epi.13334. Epub 2016 Feb 11.

22.

Delineating behavioral and cognitive phenotypes in juvenile myoclonic epilepsy: Are we missing the forest for the trees?

Valente KD, Rzezak P, Moschetta SP, de Vincentiis S, Coan AC, Guerreiro CA.

Epilepsy Behav. 2016 Jan;54:95-9. doi: 10.1016/j.yebeh.2015.10.022. Epub 2015 Dec 11.

PMID:
26687293
23.

Central nervous system involvement in sarcoidosis.

Machado VS, Silva Junior NA, Queiroz LS, Reis F, Silva Ddos S, Bueno FF, Coan AC.

Radiol Bras. 2015 Sep-Oct;48(5):334-5. doi: 10.1590/0100-3984.2014.0113. No abstract available.

24.

Aberrant topological patterns of brain structural network in temporal lobe epilepsy.

Yasuda CL, Chen Z, Beltramini GC, Coan AC, Morita ME, Kubota B, Bergo F, Beaulieu C, Cendes F, Gross DW.

Epilepsia. 2015 Dec;56(12):1992-2002. doi: 10.1111/epi.13225. Epub 2015 Nov 4.

25.

Recent developments in the genetics of childhood epileptic encephalopathies: impact in clinical practice.

Gonsales MC, Montenegro MA, Soler CV, Coan AC, Guerreiro MM, Lopes-Cendes I.

Arq Neuropsiquiatr. 2015 Nov;73(11):946-58. doi: 10.1590/0004-282X20150122. Epub 2015 Oct 6. Review.

26.

Asymptomatic carotid stenosis is associated with gray and white matter damage.

Avelar WM, D'Abreu A, Coan AC, Lima FO, Guimarães R, Yassuda CL, Oliveira GP, Guillaumon AT, Filho AA, Min LL, Cendes F.

Int J Stroke. 2015 Dec;10(8):1197-203. doi: 10.1111/ijs.12574. Epub 2015 Aug 2.

PMID:
26235564
27.

EEG-fMRI in the presurgical evaluation of temporal lobe epilepsy.

Coan AC, Chaudhary UJ, Grouiller F, Campos BM, Perani S, De Ciantis A, Vulliemoz S, Diehl B, Beltramini GC, Carmichael DW, Thornton RC, Covolan RJ, Cendes F, Lemieux L.

J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):642-9. doi: 10.1136/jnnp-2015-310401. Epub 2015 Jul 27.

PMID:
26216941
28.

Neurocysticercotic Calcifications and Hippocampal Sclerosis: A Case-Control Study.

de Oliveira Taveira M, Morita ME, Yasuda CL, Coan AC, Secolin R, Luiz Cunha da Costa A, Cendes F.

PLoS One. 2015 Jul 1;10(7):e0131180. doi: 10.1371/journal.pone.0131180. eCollection 2015.

29.

T2 hyperintense signal in patients with temporal lobe epilepsy with MRI signs of hippocampal sclerosis and in patients with temporal lobe epilepsy with normal MRI.

Kubota BY, Coan AC, Yasuda CL, Cendes F.

Epilepsy Behav. 2015 May;46:103-8. doi: 10.1016/j.yebeh.2015.04.001. Epub 2015 May 1.

PMID:
25936278
30.

Distinct domains of impulsivity are impaired in juvenile myoclonic epilepsy but not in temporal lobe epilepsy.

Rzezak P, Moschetta SP, Lima E, Castro CX, Vincentiis S, Coan AC, Guerreiro C, Filho GB, Valente KD.

Epilepsy Behav. 2015 Apr;45:44-8. doi: 10.1016/j.yebeh.2015.02.028. Epub 2015 Mar 25.

PMID:
25819744
31.

Patterns of seizure control in patients with mesial temporal lobe epilepsy with and without hippocampus sclerosis.

Coan AC, Campos BM, Bergo FP, Kubota BY, Yasuda CL, Morita ME, Guerreiro CA, Cendes F.

Arq Neuropsiquiatr. 2015 Feb;73(2):79-82. doi: 10.1590/0004-282X20140199.

32.

White matter abnormalities associate with type and localization of focal epileptogenic lesions.

Campos BM, Coan AC, Beltramini GC, Liu M, Yassuda CL, Ghizoni E, Beaulieu C, Gross DW, Cendes F.

Epilepsia. 2015 Jan;56(1):125-32. doi: 10.1111/epi.12871. Epub 2014 Dec 26.

33.

Hippocampal dysplasia with balloon cells: case report and discussion on classification.

Rogerio F, Morita ME, Coan AC, Guerreiro CA, Tedeschi H, Coras R, de Souza Queiroz L, Blümcke I, Cendes F.

J Neurol. 2014 Oct;261(10):2022-4. doi: 10.1007/s00415-014-7486-5. Epub 2014 Sep 7. No abstract available.

PMID:
25194845
34.

Memory impairment is not necessarily related to seizure frequency in mesial temporal lobe epilepsy with hippocampal sclerosis.

Pacagnella D, Lopes TM, Morita ME, Yasuda CL, Cappabianco FA, Bergo F, Balthazar ML, Coan AC, Cendes F.

Epilepsia. 2014 Aug;55(8):1197-204. doi: 10.1111/epi.12691. Epub 2014 Jun 24.

35.

Longitudinal analysis of hippocampal T2 relaxometry in FMTLE.

Suemitsu LA, Yasuda CL, Morita ME, Beltramini GC, Coan AC, Bergo F, Lopes-Cendes I, Cendes F.

Epilepsy Behav. 2014 Jul;36:154-8. doi: 10.1016/j.yebeh.2014.05.023. Epub 2014 Jun 11.

PMID:
24926943
36.

Distinct functional and structural MRI abnormalities in mesial temporal lobe epilepsy with and without hippocampal sclerosis.

Coan AC, Campos BM, Beltramini GC, Yasuda CL, Covolan RJ, Cendes F.

Epilepsia. 2014 Aug;55(8):1187-96. doi: 10.1111/epi.12670. Epub 2014 Jun 5.

37.

Frequent seizures are associated with a network of gray matter atrophy in temporal lobe epilepsy with or without hippocampal sclerosis.

Coan AC, Campos BM, Yasuda CL, Kubota BY, Bergo FP, Guerreiro CA, Cendes F.

PLoS One. 2014 Jan 27;9(1):e85843. doi: 10.1371/journal.pone.0085843. eCollection 2014.

38.

Amygdala Enlargement in Patients with Mesial Temporal Lobe Epilepsy without Hippocampal Sclerosis.

Coan AC, Morita ME, de Campos BM, Yasuda CL, Cendes F.

Front Neurol. 2013 Oct 25;4:166. doi: 10.3389/fneur.2013.00166. eCollection 2013.

39.

Reply: To PMID 24072623.

Coan AC, Cendes F.

AJNR Am J Neuroradiol. 2013 Oct;34(10):E116. doi: 10.3174/ajnr.A3751. No abstract available.

40.

Understanding the spectrum of temporal lobe epilepsy: contributions for the development of individualized therapies.

Coan AC, Cendes F.

Expert Rev Neurother. 2013 Dec;13(12):1383-94. doi: 10.1586/14737175.2013.857604. Review.

PMID:
24236904
41.

Amygdala enlargement occurs in patients with mesial temporal lobe epilepsy and hippocampal sclerosis with early epilepsy onset.

Coan AC, Morita ME, Campos BM, Bergo FP, Kubota BY, Cendes F.

Epilepsy Behav. 2013 Nov;29(2):390-4. doi: 10.1016/j.yebeh.2013.08.022. Epub 2013 Sep 24.

PMID:
24074891
42.

3T MRI quantification of hippocampal volume and signal in mesial temporal lobe epilepsy improves detection of hippocampal sclerosis.

Coan AC, Kubota B, Bergo FP, Campos BM, Cendes F.

AJNR Am J Neuroradiol. 2014 Jan;35(1):77-83. doi: 10.3174/ajnr.A3640. Epub 2013 Jul 18.

43.

Multimodal neuroimaging: potential biomarkers for response to antiepileptic drugs?

Coan AC, Cendes F.

Epilepsia. 2013 May;54 Suppl 2:67-70. doi: 10.1111/epi.12188. Review.

44.

Neuropsychiatric symptoms in Alzheimer's disease are related to functional connectivity alterations in the salience network.

Balthazar ML, Pereira FR, Lopes TM, da Silva EL, Coan AC, Campos BM, Duncan NW, Stella F, Northoff G, Damasceno BP, Cendes F.

Hum Brain Mapp. 2014 Apr;35(4):1237-46. doi: 10.1002/hbm.22248. Epub 2013 Feb 18.

PMID:
23418130
45.

Epilepsy as progressive disorders: what is the evidence that can guide our clinical decisions and how can neuroimaging help?

Coan AC, Cendes F.

Epilepsy Behav. 2013 Mar;26(3):313-21. doi: 10.1016/j.yebeh.2012.09.027. Epub 2012 Nov 3. Review.

46.

Comorbidities associated with epilepsy and headaches.

Ferreira TP, Coan AC, Guerreiro CA.

Arq Neuropsiquiatr. 2012 Apr;70(4):274-7. Epub 2012 Feb 24.

47.

Longitudinal MRI volumetric evaluation in patients with familial mesial temporal lobe epilepsy.

Conz L, Morita ME, Coan AC, Kobayashi E, Yasuda CL, Pereira AR, Lopes-Cendes I, Cendes F.

Front Neurol. 2011 Feb 14;2:5. doi: 10.3389/fneur.2011.00005. eCollection 2011.

48.

Seizure frequency and lateralization affect progression of atrophy in temporal lobe epilepsy.

Coan AC, Appenzeller S, Bonilha L, Li LM, Cendes F.

Neurology. 2009 Sep 15;73(11):834-42. doi: 10.1212/WNL.0b013e3181b783dd.

PMID:
19752449
49.

Gray matter atrophy associated with duration of temporal lobe epilepsy.

Bonilha L, Rorden C, Appenzeller S, Coan AC, Cendes F, Li LM.

Neuroimage. 2006 Sep;32(3):1070-9. Epub 2006 Jul 25.

PMID:
16872843
50.

Hippocampal abnormalities and seizure recurrence after antiepileptic drug withdrawal.

Cardoso TA, Coan AC, Kobayashi E, Guerreiro CA, Li LM, Cendes F.

Neurology. 2006 Jul 11;67(1):134-6.

PMID:
16832092

Supplemental Content

Support Center